Detection of p53 dysfunction by flow cytometry in chronic lymphocytic leukaemia
Authors:
Open Access
- 2 November 2004
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 127 (4) , 425-428
Abstract
Summary: In chronic lymphocytic leukaemia (CLL) cells, functional impairment of the p53 pathway is detectable by Western blotting as impaired up‐regulation of p21 (a transcriptional target of p53) in response to ionizing radiation (IR). The type A defect is characterized by baseline p53 overexpression and is associated with TP53 mutation. The type B defect is characterized by impaired IR‐induced p53 up‐regulation and is associated with inactivation of the ataxia telangiectasia‐mutated gene (ATM). Both abnormalities are strongly associated with adverse clinical outcome. In the present study, flow cytometry was found to be an effective alternative to Western blotting in the detection of p53 dysfunction in CLL.Keywords
This publication has 9 references indexed in Scilit:
- Mechanism of action of purine analogues in chronic lymphocytic leukaemiaBritish Journal of Haematology, 2003
- Mutation of p53 and consecutive selective drug resistance in B-CLL occurs as a consequence of prior DNA-damaging chemotherapyCell Death & Differentiation, 2003
- Relationship between p53 dysfunction, CD38 expression, andIgVH mutation in chronic lymphocytic leukemiaBlood, 2002
- p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative toTP53 mutationBlood, 2001
- Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemiaThe Lancet, 1999
- p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemiasBlood, 1995
- p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignanciesBlood, 1994
- p53-dependent apoptosis modulates the cytotoxicity of anticancer agentsCell, 1993
- p53, guardian of the genomeNature, 1992